Financial accounts reports

In this: publication
By this: publisher
In this Subject: Biotechnology
By this author: Aaronson, Colin

Author: Aaronson, Colin

Source: Journal of Commercial Biotechnology, Volume 11, Number 4, 1 July 2005 , pp. 387-389(3)

Buy & download fulltext article:

Price: $43.00 plus tax (Refund Policy)

Abstract:

Basilea Pharmaceutica AG is a Swiss-based biotechnology company whose shares are traded on the Swiss Stock Exchange. It is developing antibacterial and antifungal drugs along with dermatology treatments. The company was founded in October 2000 as a wholly owned subsidiary of F. Hoffmann-La Roche, which subsequently sold over half of the company's shares to other investors but retained approximately 33 per cent of the company at 31st December, 2004. The company's pipeline consists of the following compounds:Journal of Commercial Biotechnology (2005) 11, 387-389; doi:10.1057/palgrave.jcb.3040141

Document Type: Research article

DOI: http://dx.doi.org/10.1057/palgrave.jcb.3040141

Publication date: 2005-07-01